ADAMTS13 and thrombotic thrombocytopenic purpura: The decrease in ADAMTS13 can be the result of either congenital deficiency (homozygous or compound heterozygous ADAMTS13 mutations), or more often is attributed to the presence of autoantibodies that inhibit ADAMTS13 or clear it from the blood, accounting for around 95% of TTP cases (4).